The averages in this table were obtained by dividing the itemized total costs in Table 2 by the respective group's number of cases in need of insulin, syringes, reagent strips, glucose meters, oral drugs, hospital outpatient department consultations, hospitalization and diabetes related tests; and numbers of permanently disabled, temporary disabled, premature deaths and care givers. This evidence concerns the gene INS and diabetes mellitus.